Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1047 Neoplasms 821 Carcinoma, Non-Small-Cell Lung 806 Prostatic Neoplasms 628 Colorectal Neoplasms 536 Lung Neoplasms 489 Neoplasm Metastasis 439 Multiple Myeloma 399 Leukemia, Myeloid, Acute 392 Ovarian Neoplasms 336 Pancreatic Neoplasms 318 Melanoma 300 Squamous Cell Carcinoma of Head and Neck 269 Recurrence 260 Carcinoma, Hepatocellular 251 Glioblastoma 241 Brain Neoplasms 240 Triple Negative Breast Neoplasms 214 Head and Neck Neoplasms 211 Carcinoma, Renal Cell 211 Precursor Cell Lymphoblastic Leukemia-Lymphoma 205 Lymphoma 203 Stomach Neoplasms 200 Endometrial Neoplasms 191 Uterine Cervical Neoplasms 185 Glioma 184 Sarcoma 183 Lymphoma, Non-Hodgkin 183 Lymphoma, Large B-Cell, Diffuse 168 Hematologic Neoplasms 165

Interventions

tocilizumab 1 atezolizumab 1 Tiragolumab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Liver Cancers × 90 days × Clear all

NCT04524871 2026-05-22

MORPHEUS-LIVER

Hoffmann-La Roche

Phase 1/2 Recruiting

Advanced Liver Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡